BEXIMCO PHARMACEUTICALS ANNOUNCES SUCCESSFUL COMPLETION OF IPO

Beximco Pharmaceuticals Limited ("BPL" or the "Company"), a Bangladesh based and listed pharmaceuticals manufacturer, announces that trading in the Company's Global Depositary Receipts ("GDRs") will commence today on AIM at 8:00am under the ticker symbol BXP. The commencement of the trading follows the placing of 20,000,000 GDRs, each representing one ordinary share of Taka 10, placed at 60 pence per GDR, raising gross proceeds for Beximco Pharmaceuticals of $21 million (£12 million).

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/4012fd5940493bcb36751dbd1da534ca.html)